By Plenary Sessions: Õnne Pillak

The speaker demonstrates thorough expertise regarding the amendments to the Health Insurance and Social Tax Acts, detailing both the content of the draft bill and the opinions of various stakeholders. He explains technical aspects, such as the expansion of the social tax benefit and the reduction of the patient co-payment burden for pharmaceuticals. This expertise is also evident in the reasoned justifications provided for why certain proposals (e.g., the possibility of earlier employment) were rejected (citing the need for medical resources).